Table 1.
Indicator | 2011 | 2018 | Difference | P value |
---|---|---|---|---|
|
||||
No. of countries with a functioning influenza surveillance systema | 10/22(50%) | 19/22 (86.3%) | 36.3% | 0.0008 |
No. of countries with more than 1 sentinel site for ILI/SARI | 8 | 19 | 57.9% | 0.0001 |
No of countries reporting influenza epidemiological data to FluID for <90% of the weeks a year | 5/10 (50%) | 9/19 (47.38%) | 2.62% | 0.89 |
|
||||
No. of NICs | 13 | 16 | 15.79% | 0.25 |
No. of countries reporting influenza virological surveillance data to FluNET for 90% of the weeks a year | 9 | 16 | 36.84% | 0.01 |
No. of NICs and influenza laboratories with RT-PCR capacity | 9/13 (69.2%) | 19/19 (100%)b | 30.8% | 0.01 |
No. of NICs and influenza laboratories with capacity for influenza virus isolation | 9/13 (69.2%) | 12/16 (75%) | 5.8% | 0.73 |
No. of NICs and other influenza laboratories with sequencing capacity (including testing for antiviral susceptibility) | 3/13 (23%) | 7/16 (43.7) | 20.7% | 0.25 |
No. of NICs and other influenza laboratories participating in WHO EQAP | 9/13 (69.2%) | 19/19 (100%)b | 30.8% | 0.01 |
No. of NICs and other influenza laboratories achieving a 90% efficiency score on WHO EQAP | 11/14 (78.5%)c | 19/19 (100%)b | 21.5% | 0.03 |
|
||||
No. of countries with influenza surveillance system estimating influenza disease burden using surveillance datad | 0/10 (0%) | 6/19 (31.57%) | 31.57 | 0.04 |
|
||||
No. of countries using seasonal influenza vaccines | 12/22 (55%) | 17/22 (77%) | 22% | 0.11 |
SARI: severe acute respiratory illness, NIC: national influenza centre, RT-PCR: real-time polymerase chain reaction,EQAP: external quality assessment programme).
measured against all 21 countries and occupied Palestinian territory of the WHO Eastern Mediterranean Region.
includes three influenza laboratories which are not designated as NIC as of 2018.
includes one influenza laboratory which was not designated as NIC in 2011.
out of the countries with influenza surveillance system in 2011 (10) and 2018 (19).